256 related articles for article (PubMed ID: 20465705)
21. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
22. Acne quality of life and patient satisfaction following treatment with tretinoin pump.
Fried R; Nighland M
J Drugs Dermatol; 2009 Dec; 8(12):1080-5. PubMed ID: 20027935
[TBL] [Abstract][Full Text] [Related]
23. Anger and acne: implications for quality of life, patient satisfaction and clinical care.
Rapp DA; Brenes GA; Feldman SR; Fleischer AB; Graham GF; Dailey M; Rapp SR
Br J Dermatol; 2004 Jul; 151(1):183-9. PubMed ID: 15270889
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
[TBL] [Abstract][Full Text] [Related]
25. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
26. Profile of acne patients in the Philippines requiring a second course of oral isotretinoin.
Haryati I; Jacinto SS
Int J Dermatol; 2005 Dec; 44(12):999-1001. PubMed ID: 16409263
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne.
Laquieze S; Czernielewski J; Rueda MJ
J Drugs Dermatol; 2006; 5(10):985-90. PubMed ID: 17373148
[TBL] [Abstract][Full Text] [Related]
28. Oral isotretinoin for acne, adjusting treatment according to patient's response.
Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
[TBL] [Abstract][Full Text] [Related]
29. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
[TBL] [Abstract][Full Text] [Related]
30. Trends in prescription of acne medication in the US: shift from antibiotic to non-antibiotic treatment.
Thevarajah S; Balkrishnan R; Camacho FT; Feldman SR; Fleischer AB
J Dermatolog Treat; 2005; 16(4):224-8. PubMed ID: 16249143
[TBL] [Abstract][Full Text] [Related]
31. Medication adherence among acne patients: a review.
Lott R; Taylor SL; O'Neill JL; Krowchuk DP; Feldman SR
J Cosmet Dermatol; 2010 Jun; 9(2):160-6. PubMed ID: 20618564
[TBL] [Abstract][Full Text] [Related]
32. Low-dose isotretinoin in the treatment of acne vulgaris.
Amichai B; Shemer A; Grunwald MH
J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacoeconomy in acne--evaluation of benefit and economics].
Radtke MA; Schäfer I; Augustin M
J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S105-14. PubMed ID: 20482687
[TBL] [Abstract][Full Text] [Related]
34. Dermabrasion for acne scars during treatment with oral isotretinoin.
Bagatin E; dos Santos Guadanhim LR; Yarak S; Kamamoto CS; de Almeida FA
Dermatol Surg; 2010 Apr; 36(4):483-9. PubMed ID: 20180836
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of acne].
Jemec GB
Ugeskr Laeger; 2000 Dec; 162(50):6840-4. PubMed ID: 11187138
[TBL] [Abstract][Full Text] [Related]
37. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
Azoulay L; Oraichi D; Bérard A
Br J Dermatol; 2007 Dec; 157(6):1240-8. PubMed ID: 17970803
[TBL] [Abstract][Full Text] [Related]
38. An observational study of isotretinoin recipients treated for acne in a health maintenance organization.
McElwee NE; Schumacher MC; Johnson SC; Weir TW; Greene SL; Scotvold MJ; Hunter JR; Dinan BJ; Jick H
Arch Dermatol; 1991 Mar; 127(3):341-6. PubMed ID: 1825596
[TBL] [Abstract][Full Text] [Related]
39. Treatment of acne with intermittent isotretinoin.
Goulden V; Clark SM; McGeown C; Cunliffe WJ
Br J Dermatol; 1997 Jul; 137(1):106-8. PubMed ID: 9274635
[TBL] [Abstract][Full Text] [Related]
40. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
Johnson FR; Ozdemir S; Manjunath R; Hauber AB; Burch SP; Thompson TR
Med Care; 2007 Jun; 45(6):545-52. PubMed ID: 17515782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
